Pubblicazioni

IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Lawless, S; Sbianchi, G; Morris, C; Iacobelli, S; Bosman, P; Blaise, D; Remenyi, P; Byrne, Jl; Mayer, J; Apperley, J; Lund, J; Kobbe, G; Schaap, N; Isaksson, C; Lenhoff, S; Basak, G; Touzeau, C; Wilson, Kmo; Muniz, Sg; Scheid, C; Browne, P; Anagnostopoulos, A; Rambaldi, A; Jantunen, E; Kroger, N; Schonland, S; Yakoub-Agha, I; Garderet, L

Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT

2021 - EUROPEAN JOURNAL OF HAEMATOLOGY

Garderet, L; Sbianchi, G; Iacobelli, S; Blaise, D; Byrne, Jl; Remenyi, P; Apperley, Jf; Touzeau, C; Isaksson, C; Browne, P; Mayer, J; Lenhoff, S; Muniz, Sg; Porras, Rp; Basak, G; Poire, X; Trneny, M; Nagler, A; Michieli, M; Tanase, A; Koster, L; Hayden, Pj; Beksac, M; Schonland, S; Yakoub-Agha, I